Clinical Trial Update: Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer

View source ↗

Summary

This clinical trial update reports that the study assessing circulating and intratumoral chemokines in patients with prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Institut Bergonié | Conditions: Prostate Cancer | Status: WITHDRAWN